BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HA, Kang SH, Kim M, Lee E, Cho HM, Moon EK, Kim I. Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing's syndrome. Am J Physiol Endocrinol Metab 2018;314:E39-52. [PMID: 28928236 DOI: 10.1152/ajpendo.00267.2017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Lee HA, Lee E, Do GY, Moon EK, Quan FS, Kim I. Histone deacetylase inhibitor MGCD0103 protects the pancreas from streptozotocin-induced oxidative stress and β-cell death. Biomed Pharmacother 2019;109:921-9. [PMID: 30551546 DOI: 10.1016/j.biopha.2018.10.163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Yasuda A, Seki T, Kametani Y, Koizumi M, Kitajima N, Oki M, Seki M, Kakuta T, Fukagawa M. Glucocorticoid Receptor Antagonist Administration Prevents Adrenal Gland Atrophy in an ACTH-Independent Cushing's Syndrome Rat Model. Int J Endocrinol 2019;2019:8708401. [PMID: 30915117 DOI: 10.1155/2019/8708401] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Bartlett AA, Lapp HE, Hunter RG. Epigenetic Mechanisms of the Glucocorticoid Receptor. Trends in Endocrinology & Metabolism 2019;30:807-18. [DOI: 10.1016/j.tem.2019.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
4 Brundel BJ, Li J, Zhang D. Role of HDACs in cardiac electropathology: Therapeutic implications for atrial fibrillation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020;1867:118459. [DOI: 10.1016/j.bbamcr.2019.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Stratton MS, Farina FM, Elia L. Epigenetics and vascular diseases. J Mol Cell Cardiol 2019;133:148-63. [PMID: 31211956 DOI: 10.1016/j.yjmcc.2019.06.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
6 Aronson JK. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning. In: Lacaze A, Osimani B, editors. Uncertainty in Pharmacology. Cham: Springer International Publishing; 2020. pp. 3-38. [DOI: 10.1007/978-3-030-29179-2_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kee HJ, Ryu Y, Seok YM, Choi SY, Sun S, Kim GR, Jeong MH. Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice. Clin Hypertens 2019;25:13. [PMID: 31223486 DOI: 10.1186/s40885-019-0118-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ryu Y, Kee HJ, Sun S, Seok YM, Choi SY, Kim GR, Kee SJ, Pflieger M, Kurz T, Kim HS, Jeong MH. Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension. PLoS One 2019;14:e0213186. [PMID: 30830950 DOI: 10.1371/journal.pone.0213186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
9 Kwon DH, Ryu J, Kim YK, Kook H. Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification. Int J Mol Sci 2020;21:E3246. [PMID: 32375326 DOI: 10.3390/ijms21093246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Arifen N, Li Y, Srivastava AK, Anand-Srivastava MB. Sirtuin1 inhibitor attenuates hypertension in spontaneously hypertensive rats: role of Giα proteins and nitroxidative stress. J Hypertens 2022;40:1314-26. [PMID: 35762472 DOI: 10.1097/HJH.0000000000003143] [Reference Citation Analysis]
11 Asif S, Morrow NM, Mulvihill EE, Kim KH. Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases. Front Genet 2020;11:590369. [PMID: 33193730 DOI: 10.3389/fgene.2020.590369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Dewanjee S, Vallamkondu J, Kalra RS, Chakraborty P, Gangopadhyay M, Sahu R, Medala V, John A, Reddy PH, De Feo V, Kandimalla R. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus. Cells 2021;10:1340. [PMID: 34071497 DOI: 10.3390/cells10061340] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Zhang L, Lu Q, Chang C. Epigenetics in Health and Disease. In: Chang C, Lu Q, editors. Epigenetics in Allergy and Autoimmunity. Singapore: Springer; 2020. pp. 3-55. [DOI: 10.1007/978-981-15-3449-2_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
14 García-Eguren G, González-Ramírez M, Vizán P, Giró O, Vega-Beyhart A, Boswell L, Mora M, Halperin I, Carmona F, Gracia M, Casals G, Squarcia M, Enseñat J, Vidal O, Di Croce L, Hanzu FA. Glucocorticoid-induced fingerprints on visceral adipose tissue transcriptome and epigenome. J Clin Endocrinol Metab 2021:dgab662. [PMID: 34487152 DOI: 10.1210/clinem/dgab662] [Reference Citation Analysis]
15 Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A. Advances in the medical treatment of Cushing's syndrome. Lancet Diabetes Endocrinol 2019;7:300-12. [PMID: 30033041 DOI: 10.1016/S2213-8587(18)30155-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
16 Lamothe J, Khurana S, Tharmalingam S, Williamson C, Byrne CJ, Khaper N, Mercier S, Tai TC. The Role of DNMT and HDACs in the Fetal Programming of Hypertension by Glucocorticoids. Oxid Med Cell Longev 2020;2020:5751768. [PMID: 32318239 DOI: 10.1155/2020/5751768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Mabasa L, Samodien E, Sangweni NF, Pheiffer C, Louw J, Johnson R. In Utero One-Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction. Mol Nutr Food Res 2020;64:e1900377. [PMID: 31408914 DOI: 10.1002/mnfr.201900377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Hyndman KA, Speed JS, Mendoza LD, Allan JM, Colson J, Sedaka R, Jin C, Jung HJ, El-Dahr S, Pollock DM, Pollock JS. Fluid-electrolyte homeostasis requires histone deacetylase function. JCI Insight 2020;5:137792. [PMID: 32673289 DOI: 10.1172/jci.insight.137792] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]